A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Cecchini M, Kortmansky JS, Cui C, Wei W, Thumar JR, Uboha NV, Hafez N, Lacy J, Fischbach NA, Sabbath KD, Gomez CM, Sporn JR, Stein S, Hochster HS.
Cecchini M, et al. Among authors: wei w.
Cancer. 2021 May 1;127(9):1417-1424. doi: 10.1002/cncr.33379. Epub 2020 Dec 22.
Cancer. 2021.
PMID: 33351187
Free PMC article.
Clinical Trial.